Supplier profile
Gilead Sciences Ltd
Every public-sector award we hold for this supplier, across Czechia, Spain, France, the UK, Israel, Italy, Luxembourg, Portugal and UK, from 16 Oct 2008 to 27 Aug 2026.
Awards won
248
all time
Attributed value
£79.8m + €1.3bn + ILS 463k
139 shared, unvalued
Buyers
96
public bodies
Active
2008–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’) | 15 | £35.4m + €1.2m |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | 24 | £25.6m |
| Belfast Health & Social Care Trust | 7 | £8.0m |
| The Common Services Agency (more commonly known as NHS National Services Scotland) (“NSS”) | 4 | £7.4m |
| Southern Health and Social Care Trust | 2 | £1.5m |
| BELFAST HEALTH AND SOCIAL CARE TRUST | 2 | £1.0m |
| The Clatterbridge Cancer Centre NHS Foundation Trust | 1 | £727k |
| Northern Health and Social Care Trust | 1 | £100k |
| Leeds Teaching Hospitals NHS Trust | 1 | £15k |
| NHS England | 45 | not attributable |
What they win
Awards
Showing 1–25 of 248 awards we hold
- NHS National Generic Pharmaceuticals - Wave 16a ↗NHS Englandshared awardawarded 27 Aug 2026
- Grant Funding - Gilead Science under Grant 25759 ↗Leeds Teaching Hospitals NHS Trust£15kawarded 18 Jun 2026
- Remdesivir infusion ↗Southern Health and Social Care Trust£300kawarded 29 Apr 2026
- Biktarvy ↗Southern Health and Social Care Trust£1.2mawarded 28 Apr 2026
- HIV Medicines ↗The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)shared awardawarded 17 Apr 2026
- Provision of CAR-T Cells ↗The Clatterbridge Cancer Centre NHS Foundation Trust£727kawarded 6 Mar 2026
- NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives ↗NHS Englandshared awardawarded 25 Feb 2026
- Contrato basado en el acuerdo marco con un único proveedor Del suministro de medicamentos de uso hospitalario para el Tratamiento de la esclerosis múltiple y la infección por el virus De la inmunodeficiencia humana (VIH) a los centros hospitalarios del servicio extremeño de salud (SES) ↗Dirección General de Planificación Económica€4kawarded 18 Sept 2025
- Contrato basado en el acuerdo marco con un único proveedor Del suministro de medicamentos de uso hospitalario para el Tratamiento de la esclerosis múltiple y la infección por el virus De la inmunodeficiencia humana (VIH) a los centros hospitalarios del servicio extremeño de salud (SES) ↗Dirección General de Planificación Económica€29awarded 18 Sept 2025
- Contrato basado en el acuerdo marco con un único proveedor Del suministro de medicamentos de uso hospitalario para el Tratamiento de la esclerosis múltiple y la infección por el virus De la inmunodeficiencia humana (VIH) a los centros hospitalarios del servicio extremeño de salud (SES) ↗Dirección General de Planificación Económica€15kawarded 18 Sept 2025
- Spain – Pharmaceutical products – SUMINISTRO DEL MEDICAMENTO TECARTUS DISTRIBUIDO EN EXCLUSIVIDAD POR EL LABORATORIO GILEAD SCIENCES, S.L ↗HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA€242kawarded 2 Jul 2025
- Antiretroviral Drugs ↗Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)shared awardawarded 6 May 2025
- NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV (Lot 1) & provision of a service to supply over labelled PrEP and PEP packs (Lot 2) 1 November 2024 ↗NHS Englandshared awardawarded 28 Oct 2024
- NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV (Lot 1) & provision of a service to supply over labelled PrEP and PEP packs (Lot 2) 1 November 2024 ↗NHS Englandshared awardawarded 28 Oct 2024
- NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024 ↗NHS Englandshared awardawarded 28 Oct 2024
- SOFOSBUVIR 400mg / VELPATASVIR 100mg Tablets 28 Tablet Pack ↗BELFAST HEALTH AND SOCIAL CARE TRUST£320kawarded 23 Oct 2024
- NHS National Framework for Transition products commencing 1 October 2024 ↗NHS Englandshared awardawarded 30 Sept 2024
- NHS National Framework for Transition products commencing 1 October 2024 ↗NHS Englandshared awardawarded 30 Sept 2024
- NHS National Framework for Transition products commencing 1 October 2024 ↗NHS Englandshared awardawarded 30 Sept 2024
- France – Antineoplastic and immunomodulating agents – AO MEDICAMENTS ANTINEOPLASIQUES ET IMMUNOMODULATEURS (Classe ATC L) ↗CH de Saint-Brieuc/Paimpol/Tréguier - Etablissement support du GHT d'ARMORshared awardawarded 28 May 2024
- NP49124 Hepatitis C Medicines ↗NHS Scotlandshared awardawarded 27 Feb 2024
- NP49124 Hepatitis C Medicines ↗NHS Scotlandshared awardawarded 27 Feb 2024
- REMDESIVIR ↗BELFAST HEALTH AND SOCIAL CARE TRUST£700kawarded 7 Feb 2024
- Italy-Ancona: Pharmaceutical products ↗Azienda ospedaliero-universitaria delle Marche€280kawarded 22 Dec 2023
- Contract for Remdesivir ↗Northern Health and Social Care Trust£100kawarded 1 Dec 2023
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
- GILEAD SCIENCES, S.L.770 awards
- GILEAD SCIENCES, S.L.U.266 awards
- GILEAD SCIENCES S.R.L.183 awards
- Gilead Sciences s.r.o.157 awards
- GILEAD SCIENCES INC19 awards
- Gilead Sciences Pty Limited11 awards
- Gilead Sciences GmbH8 awards
- Gilead Sciences; SA6 awards
- Gilead Sciences SAS3 awards
- Gilead Sciences AB2 awards
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.